# DisCoVisc Comparative Evaluation

> **NCT00732225** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 173 (actual)

## Conditions studied

- Cataracts

## Interventions

- **DEVICE:** DisCoVisc
- **DEVICE:** DuoVisc
- **DEVICE:** BioVisc
- **DEVICE:** Healon5
- **DEVICE:** Amvisc Plus

## Key facts

- **NCT ID:** NCT00732225
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-02
- **Final completion:** —
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2010-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00732225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00732225, "DisCoVisc Comparative Evaluation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00732225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*